載入...
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
BACKGROUND: Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if IgG gly...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5549282/ https://ncbi.nlm.nih.gov/pubmed/28793911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1389-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|